Tuberculosis is one of the leading causes of death worldwide, with an estimated 1.4 million deaths and ten million people infected annually. Resistant and multidrug-resistant (MDR) variants of the
Researchers at Karolinska Institutet, Umeå University, and DZIF scientists at the University of Bonn have identified a new group of molecules that have an antibacterial effect against many antibiotic
